Pathstone Holdings’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.04M Buy
12,506
+1,862
+17% +$494K 0.02% 571
2026
Q1
$1.17M Buy
10,644
+478
+5% +$68.1K ﹤0.01% 1329
2025
Q4
$1.69M Sell
10,166
-413
-4% -$69.1K 0.01% 1123
2025
Q3
$2.07M Sell
10,579
-3,239
-23% -$533K 0.01% 1008
2025
Q2
$1.25M Buy
+13,818
New +$1.09M ﹤0.01% 1277
2025
Q1
Sell
-3,282
Closed -$435K 2398
2024
Q4
$435K Buy
+3,282
New +$308K ﹤0.01% 1787

Other funds holding ALAB

Pathstone Holdings's ALAB Position: Q2 2026 in Review

Pathstone Holdings increased its Astera Labs (ALAB) stake by 17% in Q2 2026, buying an estimated $494K and bringing the position to 12,506 shares worth $6.04M. The position accounts for 0.02% of the portfolio, ranked #571.

Pathstone Holdings first reported a position in ALAB in Q4 2024 and has held it in 6 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Pathstone Holdings held 12,506 shares of Astera Labs worth $6.04M as of Q2 2026.
  • Pathstone Holdings bought 1,862 Astera Labs shares in Q2 2026, an estimated $494K.
  • Astera Labs made up 0.02% of Pathstone Holdings's portfolio in Q2 2026, its #571 holding.
  • Pathstone Holdings first reported a position in Astera Labs in Q4 2024 and has held it in 6 quarters since.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.